Multifactorial White Matter Damage in the Acute Phase and Pre-Existing Conditions May Drive Cognitive Dysfunction after SARS-CoV-2 Infection: Neuropathology-Based Evidence

There is an urgent need to better understand the mechanisms underlying acute and long-term neurological symptoms after COVID-19. Neuropathological studies can contribute to a better understanding of some of these mechanisms. We conducted a detailed postmortem neuropathological analysis of 32 patient...

Full description

Saved in:
Bibliographic Details
Published in:Viruses Vol. 15; no. 4; p. 908
Main Authors: Gelpi, Ellen, Klotz, Sigrid, Beyerle, Miriam, Wischnewski, Sven, Harter, Verena, Kirschner, Harald, Stolz, Katharina, Reisinger, Christoph, Lindeck-Pozza, Elisabeth, Zoufaly, Alexander, Leoni, Marlene, Gorkiewicz, Gregor, Zacharias, Martin, Haberler, Christine, Hainfellner, Johannes, Woehrer, Adelheid, Hametner, Simon, Roetzer, Thomas, Voigtländer, Till, Ricken, Gerda, Endmayr, Verena, Haider, Carmen, Ludwig, Judith, Polt, Andrea, Wilk, Gloria, Schmid, Susanne, Erben, Irene, Nguyen, Anita, Lang, Susanna, Simonitsch-Klupp, Ingrid, Kornauth, Christoph, Nackenhorst, Maja, Kläger, Johannes, Kain, Renate, Chott, Andreas, Wasicky, Richard, Krause, Robert, Weiss, Günter, Löffler-Rag, Judith, Berger, Thomas, Moser, Patrizia, Soleiman, Afshin, Asslaber, Martin, Sedivy, Roland, Klupp, Nikolaus, Klimpfinger, Martin, Risser, Daniele, Budka, Herbert, Schirmer, Lucas, Pröbstel, Anne-Katrin, Höftberger, Romana
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 31-03-2023
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There is an urgent need to better understand the mechanisms underlying acute and long-term neurological symptoms after COVID-19. Neuropathological studies can contribute to a better understanding of some of these mechanisms. We conducted a detailed postmortem neuropathological analysis of 32 patients who died due to COVID-19 during 2020 and 2021 in Austria. All cases showed diffuse white matter damage with a diffuse microglial activation of a variable severity, including one case of hemorrhagic leukoencephalopathy. Some cases revealed mild inflammatory changes, including olfactory neuritis (25%), nodular brainstem encephalitis (31%), and cranial nerve neuritis (6%), which were similar to those observed in non-COVID-19 severely ill patients. One previously immunosuppressed patient developed acute herpes simplex encephalitis. Acute vascular pathologies (acute infarcts 22%, vascular thrombosis 12%, diffuse hypoxic-ischemic brain damage 40%) and pre-existing small vessel diseases (34%) were frequent findings. Moreover, silent neurodegenerative pathologies in elderly persons were common (AD neuropathologic changes 32%, age-related neuronal and glial tau pathologies 22%, Lewy bodies 9%, argyrophilic grain disease 12.5%, TDP43 pathology 6%). Our results support some previous neuropathological findings of apparently multifactorial and most likely indirect brain damage in the context of SARS-CoV-2 infection rather than virus-specific damage, and they are in line with the recent experimental data on SARS-CoV-2-related diffuse white matter damage, microglial activation, and cytokine release.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1999-4915
1999-4915
DOI:10.3390/v15040908